Brief Communications in 2019 | Nature Medicine
Brief Communications | Nature Medicine
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine
The future of personalized brain stimulation | Nature Medicine
Brief Communications | Nature Medicine
Nature Medicine
Brief Communications | Nature Medicine
Volume 27 Issue 5, May 2021
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes | Nature Medicine
Brief Communications in 2017 | Nature Medicine
目次 | Nature Medicine | Nature Portfolio
Brief Communications in 2018 | Nature Medicine
Brief Communications in 2017 | Nature Medicine
Brief Communications in 2020 | Nature Medicine
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
目次 | Nature Medicine | Nature Portfolio
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 | Nature Medicine
Brief Communications | Nature Medicine
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy | Nature Medicine
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 | Nature Medicine
Brief Communications in 2019 | Nature Medicine
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report | Nature Medicine
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
